CompaniesByCap
IBIO
iBio, Inc. (IBIO)
NASDAQ · Healthcare

iBio, Inc. Revenue 2011–2025

iBio, Inc. annual/quarterly revenue history and growth rate from 2011 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • iBio, Inc. revenue for the quarter ending December 31, 2025 was 0, a 100.00% decrease year-over-year.
  • iBio, Inc. revenue for the twelve months ending December 31, 2025 was 300000, a 500.00% increase year-over-year.
  • iBio, Inc. annual revenue for 2025 was 400000, a 77.78% increase from 2024.
  • iBio, Inc. annual revenue for 2024 was 225000.
  • iBio, Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2022.
  • iBio, Inc. annual revenue for 2022 was 1.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

iBio, Inc. (IBIO) — Frequently Asked Questions

iBio, Inc. (IBIO) is a publicly traded US company. It has a market capitalization of $18M. In fiscal 2025 it reported revenue of $400,000 and net income of -$18M. Explore IBIO's stock price, financial statements, earnings history, margins and key ratios below.

What is iBio, Inc.'s market cap?

iBio, Inc. (IBIO) has a market capitalization of $18M.

What is the IBIO stock price?

IBIO trades at $1.70.

How much revenue does iBio, Inc. make?

iBio, Inc. reported revenue of $400,000 in fiscal 2025.

Is IBIO profitable?

In fiscal 2025, iBio, Inc. reported net income of -$18M.